subject area of
- Agreements Between the Prothrombin Times of Blood Treated In Vitro with Heparinase During Cardiopulmonary Bypass (CPB) and Blood Sampled After CPB and Systemic Protamine Journal Articles
- Anticoagulants and Their Reversal Journal Articles
- Anti–protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis Journal Articles
- Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? Journal Articles
- Comparative effects of heparin and LMW heparin on hemostasis Conferences
- Heparin and Low-Molecular-Weight Heparin Journal Articles
- Heparin, DDAVP and the Bleeding Time Journal Articles
- Investigation of the Anticoagulant Mechanisms of a Covalent Antithrombin-Heparin Complex Journal Articles
- Management of intentional overdose of low-molecular-weight heparin Journal Articles
- Mechanisms responsible for the failure of protamine to inactivate low‐molecular‐weight heparin Journal Articles
- Neutralization of Enoxaparine-lnduced Bleeding by Protamine Sulfate Journal Articles
- Randomized, Controlled Trial of Individualized Heparin and Protamine Management in Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass Journal Articles
- Rivaroxaban for treatment of HIT: A riveting first experience Journal Articles
- Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial Journal Articles
- The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor Journal Articles